Accreditation/Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 6.75 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene, Lilly, Sirtex, and Taiho Oncology, Inc.
For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
1st Annual School of Gastrointestinal Oncology™
Saturday, April 23, 2016
Grand Hyatt New York
New York, NY
There is a need for specialized education for clinicians who manage some of the most difficult-to-treat forms of gastrointestinal cancers. The School of Gastrointestinal Oncology™ (SOGO™) will provide a multi-module curriculum-based program focused exclusively on gastrointestinal tumors’ management. This intensive 1-day interactive program will provide a comprehensive review of data on the most important aspects related to the multidisciplinary management of gastrointestinal tumors. The program will focus on the latest data on prognostic and predictive markers that impact clinical decision-making, current and emerging treatment strategies, and case-based lectures by expert faculty whose will focus on the practical application of knowledge to the complex care scenarios encountered in contemporary practice settings.
- New Frontiers in Neuroendocrine Tumor Management
- Best Practices in Sequencing Lines of Treatment in Metastatic Colorectal Cancer With or Without an Actionable Marker
- Novel Targeted Approaches in Hepatocellular Carcinoma
- A Changing Paradigm: The Potential of Immunotherapy in GI Cancers
- To Transplant or Not to Transplant: That Is the Question
This educational program is directed toward oncologists and gastroenterologists whose primary practice focus is gastrointestinal (GI) cancers and who intend to reinforce their knowledge base and expand their expertise in GI diagnosis, risk stratification, personalization of care, and best practices for multidisciplinary communication. Participants will be primarily oncologists, surgeons, gastroenterologists, interventional radiologists, radiation oncologists, fellows and other professionals who treat GI cancers whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of GI cancers.
At the conclusion of this activity, participants should be better prepared to:
- Describe current and evolving patient and tumor information that can be used to stratify risk and inform clinical decision-making in the management of gastrointestinal malignancies.
- Assess landmark clinical trial findings and apply them to changing clinical practice paradigms to personalize care and optimize outcomes.
- Delineate effective strategies to proactively mitigate and manage predictable side effects related to the management of gastrointestinal malignancies so that treatment outcomes can be maximized.
- Discuss emerging clinical trial findings on novel compounds and strategies to manage gastrointestinal malignancies.
- Apply emerging clinical trial data to manage cases in the context of evolving treatment paradigms for gastrointestinal tumors.
John Marshall, MD
Chief, Division of Hematology/Oncology
Georgetown University Hospital
Director, Ruesch Center for the Cure of GI Cancers
Michael A Choti, MD, MBA, FACS
Professor and Chair
Department of Surgery
UT Southwestern Medical Center
You must be logged in to PER to register for this meeting
Or Register for PER now
In case of onsite emergency:
Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19
I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.
I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.
* By checking this box, you have read and understand the above and agree to its terms.